Jan 16, 2018
MEDIA STATEMENT

HUMIRA® (adalimumab) Formulation Update

 

HUMIRA® (adalimumab) without citrate buffers will be made available to pediatric patients in the United States in the first half of 2018. Additional information on timing and availability will be provided to healthcare professionals in the coming months. See FULL Prescribing Information including Boxed Warning here.

 

<< Back